Skip to main content

Parkinsonism News (Page 3)

Dementia May Occur Less Often, Develop Slower in Parkinson Disease Patients

WEDNESDAY, Aug. 7, 2024 – For patients with Parkinson disease (PD), dementia may occur less often or develop over a longer time period than previously thought, according to a study published online...

Fecal Microbiota Transplant No Aid for Parkinson Disease

FRIDAY, Aug. 2, 2024 – Fecal microbiota transplantation (FMT) is safe but does not offer clinically meaningful improvements for Parkinson disease (PD), according to a study published online July 29...

Where Your Body Stores Fat Could Affect Odds for Parkinson's, Alzheimer's

THURSDAY, July 25, 2024 – Finding yourself packing on the pounds around your waist and arms? If so, you might be at heightened risk for neurological illnesses like Alzheimer's or Parkinson's, new...

Risk of Parkinson Disease Heightened in People With Anxiety

MONDAY, July 22, 2024 – The risk of developing Parkinson disease (PD) is at least doubled in people with anxiety compared with those without, according to a study published in the July issue of...

Retired Rugby Players Face Risks for Dementia, CTE

THURSDAY, July 18, 2024 – Alix Popham played in two rugby World Cups and won a Six Nations Grand Slam before retiring in 2011 as a professional in the rough-and-tumble game. By 2020, he had already...

Could Contact Sports Raise Risks for a Parkinson's-like Disorder?

WEDNESDAY, July 17, 2024 – Autopsies of deceased boxers and pro football players have long confirmed that repeat head injuries can lead to a devastating brain condition known as chronic traumatic...

Parkinsonism Occurs Frequently in Chronic Traumatic Encephalopathy

TUESDAY, July 16, 2024 – Multiple substantia nigra (SN) pathologies are associated with parkinsonism, according to a study published online July 15 in JAMA Neurology. Jason W. Adams, Ph.D., from the...

FDA Approves Ongentys (opicapone) as an Add-On Treatment for Patients with Parkinson’s Disease Experiencing “Off” Episodes

SAN DIEGO – April 27, 2020 – Neurocrine Biosciences, Inc. (Nasdaq: NBIX) today announced that the U.S. Food and Drug Administration (FDA) has approved once-daily oral Ongentys (opicapone) 25 mg and 50...

FDA Approves Xadago (safinamide) as an Add-On Treatment for Patients with Parkinson’s Disease

March 21, 2017 – The U.S. Food and Drug Administration today approved Xadago (safinamide) tablets as an add-on treatment for patients with Parkinson’s disease who are currently taking l...

FDA Medwatch Alert: Benztropine Mesylate Injection (Nexus Pharmaceuticals): Recall - Visible Particulate Matter

ISSUE: Nexus Pharmaceuticals Inc. is recalling two lots of Benztropine Mesylate Injection, USP, 2 mg/2mL (1mg/mL) in 2 mL single dose vials due to the presence of visible particulate matter in the...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Parkinson's Disease

Related drug support groups

levodopa